Reuters announced that the American Heart Association journal Circulation published an article showing Pfizer Inc.?s Bextra, a COX-2 inhibitor, can triple the risk of heart attack and stroke in certain patients. In the study, the researchers studied mice genetically prone to hardening of the arteries or atherosclerosis and found that a compound called thromboxane or […]